
Serum CYFRA21-1 levels were studied in 127 cases of colorectal cancer. The positive rates for serum CYFRA21-1 were 34.6% in primary colorectal cancer. There was a significant correlation between the positive rates of serum CYFRA21-1 and liver metastases, peritoneal dissemination, lymph node metastases, or clinical stage. The survival rate for patients in the CYFRA21-1 positive group was lower than those with CYFRA21-1 negative group. Among patients who underwent curative operation, patients is the CYFRA21-1 positive group gave a recurrence rate of 26.6%, against 9.4% in the CYFRA21-1 negative group. There was no correlation between serum CYFRA21-1 levels and serum CEA levels. These findings suggest that Serum CYFRA21-1 levels may be a useful indicator in estimating the prognosis for colorectal cancer.
Rectal Neoplasms, Liver Neoplasms, Antibodies, Monoclonal, Adenocarcinoma, Prognosis, Survival Rate, Lymphatic Metastasis, Colonic Neoplasms, Biomarkers, Tumor, Humans, Keratins, Neoplasm Invasiveness
Rectal Neoplasms, Liver Neoplasms, Antibodies, Monoclonal, Adenocarcinoma, Prognosis, Survival Rate, Lymphatic Metastasis, Colonic Neoplasms, Biomarkers, Tumor, Humans, Keratins, Neoplasm Invasiveness
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 0 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Average | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Average | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Average |
